These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 31210304

  • 1. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
    Ma SY, Wei P, Qu F.
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J, Liu HR.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
    [Abstract] [Full Text] [Related]

  • 3. LINC01116 promotes the progression of epithelial ovarian cancer via regulating cell apoptosis.
    Fang YN, Huang ZL, Li H, Tan WB, Zhang QG, Wang L, Wu JL.
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5127-5133. PubMed ID: 30178832
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S, Liu S, Feng J, Gao J, Xue F.
    Cancer Biomark; 2019 Aug; 24(4):421-428. PubMed ID: 30909184
    [Abstract] [Full Text] [Related]

  • 5. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression.
    Yao N, Sun JQ, Yu L, Ma L, Guo BQ.
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4642-4649. PubMed ID: 31210289
    [Abstract] [Full Text] [Related]

  • 6. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y, Dun Y, Zhou S, Huang XH.
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
    Gong YB, Zou YF.
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH, Liu Y, Li JL.
    Biosci Rep; 2019 Aug 30; 39(8):. PubMed ID: 31337688
    [Abstract] [Full Text] [Related]

  • 9. E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell cycle progression, inhibits apoptosis and predicts poor prognosis in epithelial ovarian cancer.
    Zhang X, Liu G, Qiu J, Zhang N, Ding J, Hua K.
    Sci Rep; 2017 Jun 30; 7(1):4469. PubMed ID: 28667302
    [Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
    Wang J, Ding W, Xu Y, Tao E, Mo M, Xu W, Cai X, Chen X, Yuan J, Wu X.
    Aging (Albany NY); 2020 Mar 12; 12(5):4558-4572. PubMed ID: 32163372
    [Abstract] [Full Text] [Related]

  • 11. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
    Zhao Q, Dong D, Chu H, Man L, Huang X, Yin L, Zhao D, Mu L, Gao C, Che J, Liu Q.
    Cell Cycle; 2021 Jun 12; 20(12):1147-1162. PubMed ID: 34110955
    [Abstract] [Full Text] [Related]

  • 12. Increased expression of long noncoding RNA HMMR-AS1 in epithelial ovarian cancer: an independent prognostic factor.
    Chu ZP, Dai J, Jia LG, Li J, Zhang Y, Zhang ZY, Yan P.
    Eur Rev Med Pharmacol Sci; 2018 Dec 12; 22(23):8145-8150. PubMed ID: 30556852
    [Abstract] [Full Text] [Related]

  • 13. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ, Lin XJ, Tang XY, Zheng TT, Zhang XY, Hua KQ.
    Int J Cancer; 2020 May 01; 146(9):2588-2598. PubMed ID: 31577838
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of lncRNA ASMTL-AS1 in Epithelial Ovarian Cancer Correlates with Worse Prognosis and Cancer Progression.
    Xu H, Tang Y, Liu L, Yan J, Qin L.
    Horm Metab Res; 2022 Jul 01; 54(7):481-488. PubMed ID: 35835145
    [Abstract] [Full Text] [Related]

  • 15. HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3.
    Dong S, Wang R, Wang H, Ding Q, Zhou X, Wang J, Zhang K, Long Y, Lu S, Hong T, Ren H, Wong K, Sheng X, Wang Y, Zeng Y.
    J Exp Clin Cancer Res; 2019 Mar 01; 38(1):110. PubMed ID: 30823895
    [Abstract] [Full Text] [Related]

  • 16. Circ-ITCH correlates with small tumor size, decreased FIGO stage and prolonged overall survival, and it inhibits cells proliferation while promotes cells apoptosis in epithelial ovarian cancer.
    Luo L, Gao Y, Sun X.
    Cancer Biomark; 2018 Mar 01; 23(4):505-513. PubMed ID: 30347599
    [Abstract] [Full Text] [Related]

  • 17. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
    Xue Z, Zhu X, Teng Y.
    Mol Med Rep; 2018 Dec 01; 18(6):5173-5181. PubMed ID: 30320385
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
    Wang X, Yang B, She Y, Ye Y.
    J Cell Biochem; 2018 Sep 01; 119(9):7790-7799. PubMed ID: 29904939
    [Abstract] [Full Text] [Related]

  • 20. LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression.
    Wu W, Gao H, Li X, Zhu Y, Peng S, Yu J, Zhan G, Wang J, Liu N, Guo X.
    Cancer Sci; 2019 May 01; 110(5):1587-1598. PubMed ID: 30941821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.